q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

One Hundred and Three (103) New Generic Equivalents Added to Medicare Part D formularies in April 2018

Category: Monthly Formulary Changes
Published: Apr, 24 2018 07:04:11
< Previous
Next >
The April, 2018 Medicare Part D formulary data updates included a total of 103 new generic equivalents (manufacturer, drug, strength, and packaging combinations) or National Drug Codes (NDCs) representing 57 different generic drugs.

What exactly is an NDC?
The National Drug Code (NDC) uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the drug and strength, and the third set of numbers identifies the packaging.

The full list of new generics is further down on this page, but here are some interesting additions to the 2018 Medicare Part D (PDP) and Medicare Advantage plan (MAPD) formularies:

*The number of formularies counts the unique formularies that offer this medication.  As a note, the same formulary can be used by one or many different Medicare Part D plans.  The same formulary can be used by both PDP and MAPD plans.

All April 2018 Generic Medications Added to Medicare Part D
The following table details the 103 manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the April 2018 updates. You can click on the NDC or Drug Name below to go to our Q1Medicare Drug Finder (Q1Rx.com) to see the details of how this drug is handled by all Medicare Part D Plans in Florida (our example state) -- You can then change the state to your state for details in your service area.

April 2018 Generic Medications Added to Medicare Part D
NDC Generic Drug Name Brand-Name Drug
42794008008 ACITRETIN 10 MG CAPSULE [Soriatane]
42794008308 ACITRETIN 25 MG CAPSULE [Soriatane]
00472031038 ADAPALENE-BNZYL PEROX 0.1-2.5% [EPIDUO]
27241004221 ALMOTRIPTAN MALATE 12.5 MG TAB [Axert]
27241004111 ALMOTRIPTAN MALATE 6.25 MG TAB [Axert]
00781232106 APREPITANT 40 MG CAPSULE [Emend]
00781232246 APREPITANT 80 MG CAPSULE [Emend]
54838057059 ARIPIPRAZOLE 1 MG/ML SOLUTION [Abilify]
65162089803 ARIPIPRAZOLE 10 MG TABLET [Abilify]
65162089903 ARIPIPRAZOLE 15 MG TABLET [Abilify]
65162089603 ARIPIPRAZOLE 2 MG TABLET [Abilify]
65162090103 ARIPIPRAZOLE 20 MG TABLET [Abilify]
65162090203 ARIPIPRAZOLE 30 MG TABLET [Abilify]
65162089703 ARIPIPRAZOLE 5 MG TABLET [Abilify]
64980037303 ATOMOXETINE HCL 10 MG CAPSULE [Strattera]
64980037903 ATOMOXETINE HCL 100 MG CAPSULE [Strattera]
64980037403 ATOMOXETINE HCL 18 MG CAPSULE [Strattera]
64980037503 ATOMOXETINE HCL 25 MG CAPSULE [Strattera]
64980037603 ATOMOXETINE HCL 40 MG CAPSULE [Strattera]
64980037703 ATOMOXETINE HCL 60 MG CAPSULE [Strattera]
64980037803 ATOMOXETINE HCL 80 MG CAPSULE [Strattera]
60505258008 ATORVASTATIN 40 MG TABLET [Lipitor]
68462040201 ATOVAQUONE-PROGUANIL 62.5-25 [Malarone]
00003256016 AZTREONAM 1000 MG INJECTION [Azactam]
00003257016 AZTREONAM 2000 MG INJECTION [Azactam]
00781716595 CALCIPOTRIENE-BETAMETHASONE DIPROPIONATE OINTMENT [Taclonex]
47781033201 CARBIDOPA 25MG TAB 100 [Lodosyn]
00378830201 CARBIDOPA-LEVODOPA-ENTACAPONE 100 MG [Stalevo]
00378830301 CARBIDOPA-LEVODOPA-ENTACAPONE 125 MG [Stalevo]
00378830501 CARBIDOPA-LEVODOPA-ENTACAPONE 200 MG [Stalevo]
00781561301 CARBIDOPA-LEVODOPA-ENTACAPONE 50 MG [Stalevo]
23155021631 CIDOFOVIR 375 MG/5 ML VIAL [Vistide]
00378082501 CLOZAPINE 25 MG TABLET [Clozaril]
66993048983 DACTINOMYCIN 0.5 MG VIAL [Cosmegen]
00409010601 DAPTOMYCIN 500 MG VIAL [Cubicin]
64980040603 EFAVIRENZ 50 MG CAPSULE [Sustiva]
68382092286 ELETRIPTAN HBR 20 MG TABLET [Relpax]
00093831118 ELETRIPTAN HBR 40 MG TABLET [Relpax]
68180013701 ESCITALOPRAM 5 MG TABLET [Lexapro]
31722056924 ESCITALOPRAM OXALATE 5 MG/5 ML [Lexapro]
00378235093 ESOMEPRAZOLE MAG DR 20 MG CAP [Nexium]
00378730753 ETHYNODIOL-ETH ESTRA 1MG-35MCG [ZOVIA]
51672401801 ETODOLAC 400 MG TABLET [LODINE]
68180036309 FENOFIBRATE 160 MG TABLET [LIPOFEN]
68180012909 FENOFIBRIC ACID DR 135 MG CAP [TRILIPIX]
00378352091 FOSAMPRENAVIR 700 MG TABLET [Lexiva]
00378696032 GLATIRAMER 20 MG/ML SYRINGE [Copaxone]
00378696112 GLATIRAMER 40 MG/ML SYRINGE [Copaxone]
00006409302 HEPATITIS B SURFACE ANTIGEN VACCINE 0.01 MG/ML PREFILLED 0.5 ML SYRINGE [Recombivax]
00006404720 HUMAN-BOVINE REASSORTANT ROTAVIRUS, LIVE PENTAVALENT (RV5) ORAL VACCINE [RotaTeq]
67457088605 HYDROXYPROGESTERONE 1.25 G/5ML [MAKENA]
60505290009 IMATINIB MESYLATE 100 MG TAB [Gleevec]
60505290103 IMATINIB MESYLATE 400 MG TAB [Gleevec]
43547037509 IRBESARTAN 150 MG TABLET [Avapro]
68180082110 LANTHANUM CARB 1,000 MG TAB CHEW [Fosrenol]
68180081942 LANTHANUM CARB 500 MG TAB CHEW [Fosrenol]
68180082046 LANTHANUM CARB 750 MG TAB CHEW [Fosrenol]
67457060020 LEVOLEUCOVORIN 175 MG/17.5 ML [Fusilev]
55150024251 LINEZOLID 600 MG/300 ML IV SOL [Zyvox]
65862060130 MODAFINIL 100 MG TABLET [Provigil]
60505252703 MODAFINIL 200 MG TABLET [Provigil]
31722072630 MONTELUKAST SOD 10 MG TABLET [Singulair]
27241001531 MONTELUKAST SOD 4 MG GRANULES [Singulair]
57237021230 MONTELUKAST SOD 4 MG TAB CHEW [Singulair]
57237021330 MONTELUKAST SOD 5 MG TAB CHEW [Singulair]
65862060330 MOXIFLOXACIN HCL 400 MG TABLET [Avelox]
65162032309 NIACIN ER 1,000 MG TABLET [Niaspan ER]
65162032109 NIACIN ER 500 MG TABLET [Niaspan ER]
65162032209 NIACIN ER 750 MG TABLET [Niaspan ER]
00003377412 NIVOLUMAB 10 MG/ML [Opdivo]
33342008407 OLANZAPINE ODT 10 MG TABLET [Zyprexa]
55111016730 OLANZAPINE 15 MG TABLET [Zyprexa]
60505311003 OLANZAPINE 2.5 MG TABLET [Zyprexa]
55111016830 OLANZAPINE 20 MG TABLET [Zyprexa]
33342008607 OLANZAPINE ODT 20 MG TABLET [Zyprexa]
43598016430 OLANZAPINE 5 MG TABLET [Zyprexa]
33342008307 OLANZAPINE ODT 5 MG TABLET [Zyprexa]
60505317007 OMEGA-3 ETHYL ESTERS 1 GM CAP [Lovaza]
69097091302 OMEPRAZOLE-BICARB 20-1,100 CAP [Zegerid]
47781038426 OSELTAMIVIR 6 MG/ML SUSPENSION [Tamiflu]
69452014713 PARICALCITOL 4 MCG CAPSULE [Zemplar]
33342005407 PIOGLITAZONE HCL 15 MG TABLET [Actos]
33342005507 PIOGLITAZONE HCL 30 MG TABLET [Actos]
33342005607 PIOGLITAZONE HCL 45 MG TABLET [Actos]
68462038160 RILUZOLE 50 MG TABLET [Rilutek]
33342009372 RIZATRIPTAN 5 MG ODT [Maxalt-MLT]
33342008750 RIZATRIPTAN 5 MG TABLET [Maxalt-MLT]
31722088390 ROSUVASTATIN CALCIUM 10 MG TAB [Crestor]
60505450409 ROSUVASTATIN CALCIUM 20 MG TAB [Crestor]
60505450503 ROSUVASTATIN CALCIUM 40 MG FILM COATED TABLET [Crestor]
31722088290 ROSUVASTATIN CALCIUM 5 MG TAB [Crestor]
45802058084 SCOPOLAMINE 1 MG/3 DAY PATCH [Transderm Scop]
65862093090 SEVELAMER 0.8 GM POWDER PACKET [RENVELA]
65862092127 SEVELAMER CARBONATE 800 MG TAB [RENVELA]
65862093190 SEVELAMER CARBONATE 40 MG/ML ORAL SUSPENSION [RENVELA]
65862042005 SULFAMETHOXAZOLE-TMP DS TABLET [Bactrim]
51672137302 TAZAROTENE 0.1% CREAM [Tazorac]
62332021030 TELMISARTAN-HCTZ 80-12.5 MG TAB [Micardis HCT]
62332021130 TELMISARTAN-HCTZ 80-25 MG TAB [Micardis HCT]
65162091446 TOBRAMYCIN 300 MG/5 ML AMPULE [Bethkis, Tobi, Tobi Podhaler, Tobramycin Sulfate]
49884035852 VIGABATRIN 500 MG POWDER PACKET [SABRIL]
60505611000 ZOLEDRONIC ACID 4 MG/5 ML VIAL [Zometa]
68382071782 ZOLMITRIPTAN 5 MG ODT [Zomig, Zomig-ZMT]

What Could the Addition of New Generic Drugs Mean to You?

  • You may be able to save money by switching from the brand-name drug to its generic equivalent – with your prescriber’s approval and a new prescription.  Please note, you will need to look carefully at coverage costs as we have found that many 2018 generics are being offered on the same tier as their brand-name equivalent or the generics do not have a significantly lower retail price.  For example, the brand-name Emend (40 mg) may be a Tier 4 drug (45% co-insurance) and the same plan may now cover the generic equivalent APREPITANT 40 MG CAPSULE also as a Tier 4 drug (45% co-insurance).  You can click here to see how your Medicare drug plan is covering these medication.

  • Your brand-name drug may no longer be available if a generic is now available.  Based on past experience, you may find that many Medicare Part D plans discontinue coverage for the brand-name drug in the months following the introduction of the generic equivalent.  If you have received notice from your Medicare Part D plan that your brand-name medication will be dropped, you should speak with your prescriber to determine if you can take the generic equivalent or if you must continue taking the brand-name drug, you will need to ask your plan for a formulary exception to continue coverage for your brand-name drug.  You can click for a chart showing the trends in formulary coverage for some of the more popular Medicare drugs and their generic equivalents.
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your service area using our Q1Rx.com.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.